cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein

Dentatorubral and pallidoluylsian atrophy (DRPLA) is a progressive neurological disorder characterized by neuronal degeneration, especially in the cerebellar dentate nucleus. DRPLA is caused by an unstable expansion of a CAG trinucleotide repeat coding for glutamine in a gene of unknown function, te...

Full description

Bibliographic Details
Main Authors: Farhat A. Khan, Russell L. Margolis, Scott L. Loev, Alan H. Sharp, Shi-Hua Li, Christopher A. Ross
Format: Article
Language:English
Published: Elsevier 1996-04-01
Series:Neurobiology of Disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996196900121
id doaj-00ee289eb5fa4d7cb5eb07bc5129bfcf
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Farhat A. Khan
Russell L. Margolis
Scott L. Loev
Alan H. Sharp
Shi-Hua Li
Christopher A. Ross
spellingShingle Farhat A. Khan
Russell L. Margolis
Scott L. Loev
Alan H. Sharp
Shi-Hua Li
Christopher A. Ross
cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein
Neurobiology of Disease
author_facet Farhat A. Khan
Russell L. Margolis
Scott L. Loev
Alan H. Sharp
Shi-Hua Li
Christopher A. Ross
author_sort Farhat A. Khan
title cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein
title_short cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein
title_full cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein
title_fullStr cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein
title_full_unstemmed cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related Protein
title_sort cdna cloning and characterization of an atrophin-1 (drpla disease gene)-related protein
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 1996-04-01
description Dentatorubral and pallidoluylsian atrophy (DRPLA) is a progressive neurological disorder characterized by neuronal degeneration, especially in the cerebellar dentate nucleus. DRPLA is caused by an unstable expansion of a CAG trinucleotide repeat coding for glutamine in a gene of unknown function, termed atrophin-1, located on chromosome 12. To gain additional understanding of atrophin-1, we have isolated a second member of the atrophin-1 gene family by screening rat cDNA libraries. The 1006-amino-acid product of this gene, which we have termed rat atrophin related protein(rARP), does not contain a glutamine repeat, but it does contain two regions of alternating acidic and basic amino residues similar to those found in atrophin-1. rARP is widely expressed as both a 7.4- and a 9.4-kb message, with enrichment in cerebellum and testis. Like atrophin-1, the rARPin vitrotranslation product migrates more slowly on SDS–polyacrylamide gel electrophoresis than predicted by molecular weight. We conclude that, at least in the rat, polyglutamine is not an essential feature of the atrophin family of genes.
url http://www.sciencedirect.com/science/article/pii/S0969996196900121
work_keys_str_mv AT farhatakhan cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein
AT russelllmargolis cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein
AT scottlloev cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein
AT alanhsharp cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein
AT shihuali cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein
AT christopheraross cdnacloningandcharacterizationofanatrophin1drpladiseasegenerelatedprotein
_version_ 1724211391396577280
spelling doaj-00ee289eb5fa4d7cb5eb07bc5129bfcf2021-03-20T05:00:11ZengElsevierNeurobiology of Disease1095-953X1996-04-0132121128cDNA Cloning and Characterization of an Atrophin-1 (DRPLA Disease Gene)-Related ProteinFarhat A. Khan0Russell L. Margolis1Scott L. Loev2Alan H. Sharp3Shi-Hua Li4Christopher A. Ross5Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Laboratory of Molecular Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Laboratory of Molecular Neurobiology, Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196Dentatorubral and pallidoluylsian atrophy (DRPLA) is a progressive neurological disorder characterized by neuronal degeneration, especially in the cerebellar dentate nucleus. DRPLA is caused by an unstable expansion of a CAG trinucleotide repeat coding for glutamine in a gene of unknown function, termed atrophin-1, located on chromosome 12. To gain additional understanding of atrophin-1, we have isolated a second member of the atrophin-1 gene family by screening rat cDNA libraries. The 1006-amino-acid product of this gene, which we have termed rat atrophin related protein(rARP), does not contain a glutamine repeat, but it does contain two regions of alternating acidic and basic amino residues similar to those found in atrophin-1. rARP is widely expressed as both a 7.4- and a 9.4-kb message, with enrichment in cerebellum and testis. Like atrophin-1, the rARPin vitrotranslation product migrates more slowly on SDS–polyacrylamide gel electrophoresis than predicted by molecular weight. We conclude that, at least in the rat, polyglutamine is not an essential feature of the atrophin family of genes.http://www.sciencedirect.com/science/article/pii/S0969996196900121